共 50 条
- [32] Efficacy and Safety of Voclosporin Over 3 Years in Patients With Severe Lupus Nephritis [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 33 - 33
- [33] The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 385 - 394
- [34] Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (08): : 773 - 781
- [36] Adding belimumab improves lupus nephritis [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (11) : 601 - 601
- [37] Adding belimumab improves lupus nephritis [J]. Nature Reviews Rheumatology, 2020, 16 : 601 - 601
- [39] Long-Term Safety and Efficacy of Voclosporin in Patients With Lupus Nephritis and Low eGFR [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 184 - 185